The first stop for professional medicines advice

Medicines planning

44 results

Applied filters

Primary care discussions: biosimilar insulin

30 September 2025Discussion about the considerations of implementing biosimilar insulin in primary care. Hints and tips for systems considering a move to biosimilar insulin.

Understanding biological and biosimilar medicines

1 August 2025Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions

Biosimilar and key generic medicines – September 2025 update

11 September 2025An update about biosimilar and key generic medicines to support system mobilisation.

Understanding data exclusivity and market protection

11 July 2025Data exclusivity and market protection periods prevent generic or biosimilar competition for at least 10 years after the originator medicine is licensed.

Understanding patents

11 July 2025Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines.

Understanding biosimilar and generic market entry

11 July 2025New medicines have several protections against competition. Other factors influence availability of biosimilars or generics after loss of exclusivity.

Biosimilar and key generic medicines July 2025 update

9 July 2025An update supporting system implementation of biosimilar and key generic medicines.

Preparing to use aflibercept 2mg biosimilar

4 July 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.

Preparing to use golimumab biosimilar

21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.

National Homecare Medicines Committee regional contacts

12 May 2025Contact details of the homecare regional specialists within the UK who sit on the National Homecare Medicines Committee (NHMC).